Skip to main content

Articles

Page 2 of 59

  1. SGLT2 inhibitors and DPP4 inhibitors have been suggested to affect lipid metabolism. However, there are few randomized controlled trials comparing the effects on the lipid metabolism between the two types of a...

    Authors: Mototsugu Nagao, Jun Sasaki, Kyoko Tanimura-Inagaki, Ichiro Sakuma, Hitoshi Sugihara and Shinichi Oikawa
    Citation: Cardiovascular Diabetology 2024 23:56
  2. Hypoglycaemia has been shown to induce a systemic pro-inflammatory response, which may be driven, in part, by the adrenaline response. Prior exposure to hypoglycaemia attenuates counterregulatory hormone respo...

    Authors: Clementine E. M. Verhulst, Julia I. P. van Heck, Therese W. Fabricius, Rinke Stienstra, Steven Teerenstra, Rory J. McCrimmon, Cees J. Tack, Ulrik Pedersen-Bjergaard and Bastiaan E. de Galan
    Citation: Cardiovascular Diabetology 2024 23:55
  3. The atherogenic index of plasma (AIP) and cardiovascular disease (CVD) in participants with abnormal glucose metabolism have been linked in previous studies. However, it was unclear whether AIP control level a...

    Authors: Qianqian Min, Zhigang Wu, Jiangnan Yao, Siyi Wang, Lanzhi Duan, Sijia Liu, Mei Zhang, Yanhong Luo, Dongmei Ye, Yuxu Huang, Lan Chen, Ke Xu and Jianghua Zhou
    Citation: Cardiovascular Diabetology 2024 23:54
  4. Coronary heart disease (CHD) is a major global health concern, especially among individuals with type 2 diabetes (T2D). Given the crucial role of proteins in various biological processes, this study aimed to e...

    Authors: Hong Luo, Marie-Theres Huemer, Agnese Petrera, Stefanie M. Hauck, Wolfgang Rathmann, Christian Herder, Wolfgang Koenig, Annika Hoyer, Annette Peters and Barbara Thorand
    Citation: Cardiovascular Diabetology 2024 23:53
  5. The outcomes of percutaneous coronary intervention (PCI) in diabetic patients are still suboptimal, and it is unclear if diabetic patients might derive a benefit from the use of drug-coated balloons.

    Authors: Gianluca Caiazzo, Angelo Oliva, Luca Testa, Tay M. Heang, Chuey Y. Lee, Diego Milazzo, Giulio Stefanini, Nicola Pesenti, Antonio Mangieri, Antonio Colombo and Bernardo Cortese
    Citation: Cardiovascular Diabetology 2024 23:52
  6. It has been confirmed that the ApoB/ApoA1 ratio is closely associated with the incidence of cardiometabolic diseases (CMD). However, due to uncontrolled confounding factors in observational studies, the causal...

    Authors: Chao Fu, Dongbo Liu, Qi Liu, Xuedong Wang, Xiaoxue Ma, Hong Pan, Shi Feng, Zhao Sun, Weishen Qiao, Mengyue Yang, Shuang Gao, Hongyu Ding, Xingtao Huang and Jingbo Hou
    Citation: Cardiovascular Diabetology 2024 23:51
  7. Diabetes mellitus is a chronic disease which is detrimental to cardiovascular health, often leading to secondary microvascular complications, with huge global health implications. Therapeutic interventions tha...

    Authors: Monica Gamez, Hesham E. Elhegni, Sarah Fawaz, Kwan Ho Ho, Neill W. Campbell, David A. Copland, Karen L. Onions, Matthew J. Butler, Elizabeth J. Wasson, Michael Crompton, Raina D. Ramnath, Yan Qiu, Yu Yamaguchi, Kenton P. Arkill, David O. Bates, Jeremy E. Turnbull…
    Citation: Cardiovascular Diabetology 2024 23:50

    The Correction to this article has been published in Cardiovascular Diabetology 2024 23:74

  8. Diabetic cardiomyopathy (DbCM) is a form of Stage B heart failure (HF) at high risk for progression to overt disease. Using baseline characteristics of study participants from the Aldose Reductase Inhibition f...

    Authors: James L. Januzzi, Stefano Del Prato, Julio Rosenstock, Javed Butler, Justin Ezekowitz, Nasrien E. Ibrahim, Carolyn S.P. Lam, Thomas Marwick, W. H. Wilson Tang, Yuxi Liu, Reza Mohebi, Alessia Urbinati, Faiez Zannad and Riccardo Perfetti
    Citation: Cardiovascular Diabetology 2024 23:49
  9. The impact of the coexistence of type 2 diabetes mellitus (T2DM) in patients with non-ischemic dilated cardiomyopathy (DCM) on clinical profiles, myocardial fibrosis, and outcomes remain incompletely understood.

    Authors: Yangjie Li, Hong Xian, Yuanwei Xu, Weihao Li, Jiajun Guo, Ke Wan, Jie Wang, Ziqian Xu, Qing Zhang, Yuchi Han, Jiayu Sun and Yucheng Chen
    Citation: Cardiovascular Diabetology 2024 23:48
  10. Underweight imposes significant burden on cardiovascular outcomes in patients with diabetes mellitus. However, less is known about the impact of serial change in body weight status measured as body mass index ...

    Authors: Joo Hee Jeong, Yun Gi Kim, Kyung-Do Han, Seung-Young Roh, Hyoung Seok Lee, Yun Young Choi, Jaemin Shim, Jong-Il Choi and Young-Hoon Kim
    Citation: Cardiovascular Diabetology 2024 23:46
  11. This study used a bidirectional 2-sample Mendelian randomization study to investigate the potential causal links between mtDNA copy number and cardiometabolic disease (obesity, hypertension, hyperlipidaemia, t...

    Authors: Pei Qin, Tianhang Qin, Lei Liang, Xinying Li, Bin Jiang, Xiaojie Wang, Jianping Ma, Fulan Hu, Ming Zhang and Dongsheng Hu
    Citation: Cardiovascular Diabetology 2024 23:45
  12. The prognostic value of triglyceride-glucose (TyG) index in general type 2 diabetes mellitus (T2DM) patients is still unclear. Therefore, we aimed to determine the associations between TyG and all-cause/cause-...

    Authors: Younan Yao, Bo Wang, Tian Geng, Jiyan Chen, Wan Chen and Liwen Li
    Citation: Cardiovascular Diabetology 2024 23:43
  13. Asialoglycoprotein receptor 1 (ASGR1), primarily expressed on hepatocytes, promotes the clearance and the degradation of glycoproteins, including lipoproteins, from the circulation. In humans, loss-of-function...

    Authors: Monika Svecla, Lorenzo Da Dalt, Annalisa Moregola, Jasmine Nour, Andrea Baragetti, Patrizia Uboldi, Elena Donetti, Lorenzo Arnaboldi, Giangiacomo Beretta, Fabrizia Bonacina and Giuseppe Danilo Norata
    Citation: Cardiovascular Diabetology 2024 23:42
  14. It is well-known that systemic inflammation plays a crucial role in the pathogenesis and prognosis of acute myocardial infarction (AMI). The systemic immune-inflammation index (SII, platelet × neutrophil/lymph...

    Authors: Jiachen Luo, Xiaoming Qin, Xingxu Zhang, Yiwei Zhang, Fang Yuan, Wentao Shi, Baoxin Liu and Yidong Wei
    Citation: Cardiovascular Diabetology 2024 23:41
  15. The triglyceride-glucose (TyG) index is regarded as a dependable alternative for assessing insulin resistance (IR), given its simplicity, cost-effectiveness, and strong correlation with IR. The relationship be...

    Authors: Benchuan Hao, Lyu Lyu, Juan Xu, Xiaoqing Zhu, Cui Xu, Weiyang Gao, Ji Qin, Taoke Huang, Yipu Ding, Ziyue Zhang, Yanhui Yang and Hongbin Liu
    Citation: Cardiovascular Diabetology 2024 23:40
  16. The triglyceride-glucose (TyG) index has been linked to the onset, progression, and prognosis of cardiovascular disease (CVD) in middle-aged and elderly individuals. Nevertheless, the relationship between the ...

    Authors: Dachuan Guo, Zhenguo Wu, Fei Xue, Sha Chen, Xiangzhen Ran, Cheng Zhang and Jianmin Yang
    Citation: Cardiovascular Diabetology 2024 23:39
  17. Legume consumption has been linked to a reduced risk of type 2 diabetes (T2D) and cardiovascular disease (CVD), while the potential association between plasma metabolites associated with legume consumption and...

    Authors: Hernando J. Margara-Escudero, Indira Paz-Graniel, Jesús García-Gavilán, Miguel Ruiz-Canela, Qi Sun, Clary B. Clish, Estefania Toledo, Dolores Corella, Ramón Estruch, Emilio Ros, Olga Castañer, Fernando Arós, Miquel Fiol, Marta Guasch-Ferré, José Lapetra, Cristina Razquin…
    Citation: Cardiovascular Diabetology 2024 23:38
  18. Higher levels of palmitoyl sphingomyelin (PSM, synonymous with sphingomyelin 16:0) are associated with an increased risk of cardiovascular disease (CVD) in people with diabetes. Whether circulating PSM levels ...

    Authors: Xin Qian, Hongmei Jia, Jinping Wang, Siyao He, Meng Yu, Xinxing Feng, Qiuhong Gong, Yali An, Xuan Wang, Na Shi, Hui Li, Zhongmei Zou, Guangwei Li and Yanyan Chen
    Citation: Cardiovascular Diabetology 2024 23:37
  19. Type 2 diabetes mellitus (T2DM) increases the risk of coronary heart disease (CHD) by 2–4 fold, and is associated with endothelial dysfunction, dyslipidaemia, insulin resistance, and chronic hyperglycaemia. Th...

    Authors: Francesco Piarulli, Cristina Banfi, Eugenio Ragazzi, Erica Gianazza, Marco Munno, Massimo Carollo, Pietro Traldi, Annunziata Lapolla and Giovanni Sartore
    Citation: Cardiovascular Diabetology 2024 23:36
  20. Diabetes mellitus (DM) is associated with a worse prognosis in patients with heart failure. Our aim was to analyze the clinical and imaging features of patients with DM and their association with outcomes in c...

    Authors: Pablo Zulet, Fabián Islas, Marcos Ferrández-Escarabajal, Ana Bustos, Beatriz Cabeza, Sandra Gil-Abizanda, María Vidal, Irene Martín-Lores, Paula Hernández-Mateo, J. Alberto de Agustín and Carmen Olmos
    Citation: Cardiovascular Diabetology 2024 23:35
  21. Foot ulcers and/or infections are common long-term complications of diabetes and are associated with increased mortality, especially from cardiovascular disease, though only a few studies have investigated the...

    Authors: Martina Vitale, Emanuela Orsi, Anna Solini, Monia Garofolo, Veronica Resi, Enzo Bonora, Cecilia Fondelli, Roberto Trevisan, Monica Vedovato, Giuseppe Penno and Giuseppe Pugliese
    Citation: Cardiovascular Diabetology 2024 23:34
  22. Cardiovascular diseases (CVDs) remain a major global health concern, necessitating advanced risk assessment beyond traditional factors. Early vascular aging (EVA), characterized by accelerated vascular changes...

    Authors: Iván Cavero-Redondo, Alicia Saz-Lara, Irene Martínez-García, Iris Otero-Luis and Arturo Martínez-Rodrigo
    Citation: Cardiovascular Diabetology 2024 23:33
  23. Chen et al. recently related the skin autofluorescence (SAF) of Advanced Glycation End-products to subclinical cardiovascular disease in the 3001 participants from the general population (Rotterdam study), wit...

    Authors: Fadi Alkhami, Gauthier Borderie, Ninon Foussard, Alice Larroumet, Laurence Blanco, Marie-Amélie Barbet-Massin, Amandine Ferriere, Claire Ducos, Kamel Mohammedi, Sami Fawaz, Thierry Couffinhal and Vincent Rigalleau
    Citation: Cardiovascular Diabetology 2024 23:32
  24. Type 1 diabetes (T1D) is a significant risk factor for a range of cardiovascular diseases. Nonetheless, the causal relationship between T1D and non-ischemic cardiomyopathy (NICM) remains to be elucidated. Furt...

    Authors: Yunyue Zhao, Enxi Quan, Tao Zeng, Zhuoshan Huang, Yanting Luo, Long Peng, Suhua Li, Jinlai Liu, Yutian Chong and Hong Cao
    Citation: Cardiovascular Diabetology 2024 23:31
  25. Individuals who are overweight or obese often develop insulin resistance, mediation of the association between body mass index (BMI) and stroke risk through the triglyceride-glucose index (TyG) seems plausible...

    Authors: Rong-Rui Huo, Qian Liao, Lu Zhai, Xue-Mei You and Yan-Li Zuo
    Citation: Cardiovascular Diabetology 2024 23:30
  26. The stress hyperglycemia ratio (SHR) has been demonstrated as an independent risk factor for acute kidney injury (AKI) in certain populations. However, this relationship in patients with congestive heart failu...

    Authors: Le Li, Ligang Ding, Lihui Zheng, Lingmin Wu, Zhicheng Hu, Limin Liu and Yan Yao
    Citation: Cardiovascular Diabetology 2024 23:29
  27. Sarcopenia is frequently found in patients with heart failure with reduced ejection fraction (HFrEF) and is associated with reduced exercise capacity, poor quality of life and adverse outcomes. Recent evidence...

    Authors: Ke Shi, Ge Zhang, Hang Fu, Xue-Ming Li, Shi-Qin Yu, Rui Shi, Wei-Feng Yan, Wen-Lei Qian, Hua-Yan Xu, Yuan Li, Ying-Kun Guo and Zhi-Gang Yang
    Citation: Cardiovascular Diabetology 2024 23:28
  28. The triglyceride-glucose (TyG) index, identified as a reliable indicator of insulin resistance (IR), was reported to be associated with stroke recurrence and morbidity in the general population and critically ...

    Authors: Zhendong Ding, Mian Ge, Yuexiang Tan, Chaojin Chen and Ziqing Hei
    Citation: Cardiovascular Diabetology 2024 23:27
  29. To investigate the correlation between triglyceride glucose index (TyG) and collateral circulation in patients with chronic total occlusion (CTO) of coronary arteries in different glucose metabolic states.

    Authors: Junwei Zhu, Minghui Niu, Chenxing Wang, Ying Liang, Rong Guo and Fei He
    Citation: Cardiovascular Diabetology 2024 23:26
  30. Females are generally less prone to cardiovascular (CV) events than males, but this protection is trumped by diabetes. The mechanism behind the increased relative risk in females with diabetes is not fully und...

    Authors: Alessia Riccio, Elena Fortin, Linda Mellbin, Anna Norhammar, Per Näsman, Lars Rydén, Giorgio Sesti and Giulia Ferrannini
    Citation: Cardiovascular Diabetology 2024 23:25
  31. Studies have shown that insulin resistance is strongly associated with the development of cardiovascular disease, and the triglyceride glucose-body mass index (TyG-BMI index) is considered to be a reliable sur...

    Authors: Xueyuan Yang, Kui Li, Jiaojiao Wen, Changlong Yang, Yunhang Li, Guanxue Xu and Yi Ma
    Citation: Cardiovascular Diabetology 2024 23:24
  32. The TyG index, a prominent metric for assessing insulin resistance, has gained traction as a prognostic tool for cardiovascular disease. Nevertheless, the understanding of the prognostic significance of the ex...

    Authors: Zhengwen Xu, Peixian Chen, Lian Wang, Jie Yan, Xisheng Yan and Dongsheng Li
    Citation: Cardiovascular Diabetology 2024 23:23
  33. Myocardial infarction (MI), stroke, peripheral arterial disease (PAD), heart failure (HF) and chronic kidney disease (CKD) are common cardiovascular renal diseases (CVRD) manifestations for type 2 diabetes. Th...

    Authors: Patrick Blin, Michael Joubert, Patrick Jourdain, Philippe Zaoui, Estelle Guiard, Dunia Sakr, Caroline Dureau-Pournin, Marie-Agnès Bernard, Régis Lassalle, Florence Thomas-Delecourt, Sébastien Bineau, Nicholas Moore and Cécile Droz-Perroteau
    Citation: Cardiovascular Diabetology 2024 23:22
  34. Atherosclerosis is one of the leading causes of death worldwide. miR-26 is a potential biomarker of atherosclerosis. Standardized diagnostic tests for miR-26 (MIR26-DX) have been developed, but the fastest pro...

    Authors: Wujun Chen, Xiaolin Wu, Jianxia Hu, Xiaolei Liu, Zhu Guo, Jianfeng Wu, Yingchun Shao, Minglu Hao, Shuangshuang Zhang, Weichao Hu, Yanhong Wang, Miao Zhang, Meng Zhu, Chao Wang, Yudong Wu, Jie Wang…
    Citation: Cardiovascular Diabetology 2024 23:21
  35. Remnant cholesterol (RC) is implicated in the risk of cardiovascular disease. However, comprehensive population-based studies elucidating its association with aortic valve calcium (AVC) progression are limited...

    Authors: Ze-Hua Li, Qing-Yun Hao, Yu-Hong Zeng, Jing-Bin Guo, Shi-Chao Li, Jing-Wei Gao and Ping-Zhen Yang
    Citation: Cardiovascular Diabetology 2024 23:20
  36. Diabetic cardiomyopathy (DCM) is a major cause of mortality in patients with diabetes, and the potential strategies for treating DCM are insufficient. Melatonin (Mel) has been shown to attenuate DCM, however, ...

    Authors: Shengzheng Zhang, Wencong Tian, Xianxian Duan, Qian Zhang, Lei Cao, Chunlei Liu, Guangru Li, Ziwei Wang, Junwei Zhang, Jing Li, Liang Yang, Yang Gao, Yang Xu, Jie Liu, Jie Yan, Jianlin Cui…
    Citation: Cardiovascular Diabetology 2024 23:19
  37. Increased risk of severe tachyarrhythmias is reported in patients with type 2 diabetes mellitus (T2DM). The aim of this study was to explore if treatment with cardiac implantable electronic device (CIED) such ...

    Authors: Elina Rautio, Fredrik Gadler, Soffia Gudbjörnsdottir, Stefan Franzén, Lars Rydén, Gianluigi Savarese, Ann-Marie Svensson and Linda G. Mellbin
    Citation: Cardiovascular Diabetology 2024 23:18
  38. Atherosclerosis is closely linked with glucose metabolism. We aimed to investigate the role of the atherogenic index of plasma (AIP) in the reversal of prediabetes to normal blood glucose levels or its progres...

    Authors: Hongyi Yang, Maobin Kuang, Ruijuan Yang, Guobo Xie, Guotai Sheng and Yang Zou
    Citation: Cardiovascular Diabetology 2024 23:17
  39. Findings from earlier research have established that insulin resistance (IR) is implicated in atherosclerosis progression, representing a noteworthy risk factor for cardiovascular disease (CVD). Recently, the ...

    Authors: Fadong Li, Yue Wang, Boqun Shi, Shuaifeng Sun, Shen Wang, Shuo Pang and Xiaofan Wu
    Citation: Cardiovascular Diabetology 2024 23:16
  40. Insulin resistance (IR), a hallmark of proceeding diabetes and cardiovascular (CV) disease, has been shown to predict prognosis in patients undergoing percutaneous coronary intervention (PCI). The triglyceride...

    Authors: Jining He, Chenxi Song, Sheng Yuan, Xiaohui Bian, Zhangyu Lin, Min Yang and Kefei Dou
    Citation: Cardiovascular Diabetology 2024 23:15
  41. To delineate the metabolomic differences in plasma samples between patients with coronary artery disease (CAD) and those with concomitant CAD and type 2 diabetes mellitus (T2DM), and to pinpoint distinctive me...

    Authors: Yingjian Liu, Ju-e Liu, Huafeng He, Min Qin, Heping Lei, Jinxiu Meng, Chen Liu, Xiaoping Chen, Wenwei Luo and Shilong Zhong
    Citation: Cardiovascular Diabetology 2024 23:14
  42. Metabolic effects of empagliflozin treatment include lowered glucose and insulin concentrations, elevated free fatty acids and ketone bodies and have been suggested to contribute to the cardiovascular benefits...

    Authors: Roopameera Thirumathyam, Erik Arne Richter, Gerrit van Hall, Jens Juul Holst, Mogens Fenger, Jens P. Gøtze, Ulrik Dixen, Niels Vejlstrup, Sten Madsbad, Per Lav Madsen and Nils Bruun Jørgensen
    Citation: Cardiovascular Diabetology 2024 23:13
  43. Abnormal lipid metabolism poses a risk for prediabetes. However, research on lipid parameters used to predict the risk of prediabetes is scarce, and the significance of traditional and untraditional lipid para...

    Authors: Mingkang Li, Wenkang Zhang, Minhao Zhang, Linqing Li, Dong Wang, Gaoliang Yan, Yong Qiao and Chengchun Tang
    Citation: Cardiovascular Diabetology 2024 23:12
  44. The role of triglyceride-glucose (TyG) index, an insulin resistance indicator, in glycemic management for diabetic patients with coronary artery disease (CAD) was still unknown. Therefore, we aimed to explore ...

    Authors: Zhangyu Lin, Jining He, Sheng Yuan, Chenxi Song, Xiaohui Bian, Min Yang and Kefei Dou
    Citation: Cardiovascular Diabetology 2024 23:11
  45. Few studies explored the effect of the combination of glucose sodium-cotransporter-2 inhibitors (SGLT-2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA) on the incidence of cardiovascular events in pa...

    Authors: Raffaele Marfella, Francesco Prattichizzo, Celestino Sardu, Pier Francesco Rambaldi, Carlo Fumagalli, Ludovica Vittoria Marfella, Rosalba La Grotta, Chiara Frigé, Valeria Pellegrini, Davide D’Andrea, Arturo Cesaro, Paolo Calabrò, Carmine Pizzi, Roberto Antonicelli, Antonio Ceriello, Ciro Mauro…
    Citation: Cardiovascular Diabetology 2024 23:10
  46. Microvascular pathology is one of the main characteristics of diabetic cardiomyopathy; however, the early longitudinal course of diabetic microvascular dysfunction remains uncertain. This study aimed to invest...

    Authors: Li Jiang, Wei‑Feng Yan, Lu Zhang, Hua‑Yan Xu, Ying‑Kun Guo, Zhen-Lin Li, Ke-Ling Liu, Ling-Ming Zeng, Yuan Li and Zhi-Gang Yang
    Citation: Cardiovascular Diabetology 2024 23:9
  47. In the American population, the relationship between the triglyceride-glucose (TyG) index and TYG combined with indicators of obesity and cardiovascular disease (CVD) and its mortality has been less well studied.

    Authors: Keke Dang, Xuanyang Wang, Jinxia Hu, Yuntao Zhang, Licheng Cheng, Xiang Qi, Lin Liu, Zhu Ming, Xinmiao Tao and Ying Li
    Citation: Cardiovascular Diabetology 2024 23:8
  48. The diabetogenic effect of statins has been well established by clinical trials, Mendelian randomisation studies and meta-analyses. According to large clinical trials, PCSK9 inhibitors (PCSK9i) have no deleter...

    Authors: Ana M. González-Lleó, Rosa M. Sánchez-Hernández, Núria Plana, Daiana Ibarretxe, Pere Rehues, Josep Ribalta, Dídac Llop, Ana M. Wägner, Lluís Masana and Mauro Boronat
    Citation: Cardiovascular Diabetology 2024 23:4

Cardiovascular Diabetology is affiliated with Sackler Faculty of Medicine, Tel-Aviv University

New Content Item

Annual Journal Metrics

  • 2022 Citation Impact
    9.3 - 2-year Impact Factor
    9.6 - 5-year Impact Factor
    2.054 - SNIP (Source Normalized Impact per Paper)
    2.361 - SJR (SCImago Journal Rank)

    2023 Speed
    4 days submission to first editorial decision for all manuscripts (Median)
    56 days submission to accept (Median)

    2023 Usage 
    2,523,778 downloads
    3,115 Altmetric mentions